Proxygen GmbH | Finanzwire

Basculer en Français

10796	Companies
233363	Keywords
162043	Articles
124567	Press releases

Home
Companies
Proxygen GmbH

BRIEF

published on 04/28/2026 at 14:05, 3 months 5 days ago

Proxygen Advances in Induced Proximity Therapeutics with New Programs

Biotechnology Cancer Therapeutics Proxygen Induced Proximity
PRESS RELEASE

published on 04/28/2026 at 14:00, 3 months 5 days ago

Proxygen Expands Platform Beyond Degradation to Build Next-Generation Induced Proximity Therapeutics
Proxygen announces expansion of platform to develop next-generation induced proximity therapeutics, advancing p300 and CDK12 programs focused on multiple cancer types

Drug Discovery Molecular Glue Degraders Proxygen Induced Proximity Therapeutics Cancer Types
BRIEF

published on 03/31/2026 at 14:05, 4 months 3 days ago

Proxygen Names Chiara Conti as Chief Scientific Officer

Biotechnology Clinical Development Molecular Glue Degraders Proxygen GmbH Chiara Conti
PRESS RELEASE

published on 03/31/2026 at 14:00, 4 months 3 days ago

Proxygen Appoints Chiara Conti, Ph.D. as Chief Scientific Officer to Drive Clinical Translation and Expand Induced Proximity Platform Beyond Degradation
Proxygen appoints Dr. Chiara Conti as Chief Scientific Officer to drive clinical translation and expand induced proximity platform. Company transitions to clinical-stage execution with a focus on advancing the pipeline

Chief Scientific Officer Clinical Translation Chiara Conti Proxygen Proximity-based Therapeutics

Accesswire

Published on 08/03/2026 at 23:00, 4 hours 17 minutes ago

Viemed Healthcare Announces Second Quarter 2026 Financial Results
Published on 08/01/2026 at 01:20, 3 days 1 hour ago

Gamma Resources Announces $880,000 Private Placement with Full Warrant Coverage
Published on 08/01/2026 at 01:15, 3 days 2 hours ago

Clean Air Metals and Fiore-Backed Springbok Ventures Announce Strategic Business Combination
Published on 08/01/2026 at 00:30, 3 days 2 hours ago

Battery X Metals Announces Amendment to Corporate Awareness Engagement
Published on 08/01/2026 at 00:25, 3 days 2 hours ago

BioNxt Solutions Announces Option Grants

View all ACCESSWIRE

EQS Group

Published on 08/03/2026 at 23:33, 3 hours 43 minutes ago

EQS-Adhoc: Verbio SE: Preliminary EBITDA for FY 2025/2026 exceeds forecast
Published on 08/03/2026 at 23:20, 3 hours 57 minutes ago

DeFi Technologies Announces Shareholder Call to Discuss Q2 2026 Financial Results
Published on 08/03/2026 at 21:39, 5 hours 38 minutes ago

PAUL Tech AG reports net income after tax of EUR 3.2 million for fiscal year 2025 and issues a positive outlook for fiscal year 2026
Published on 08/03/2026 at 19:35, 7 hours 42 minutes ago

Enzene Launches NeX™, a Comprehensive Suite of Solutionsto Enable Cost-Efficient, High-Yielding Local Biomanufacturing
Published on 08/03/2026 at 19:01, 8 hours 16 minutes ago

EQS-Adhoc: Fresenius Medical Care AG : Fresenius Medical Care reports operating income excluding special items to be above market expectations in Q2 2026 and confirms its outlook for the financial year 2026

Les Echos

Published on 08/03/2026 at 18:45, 8 hours 32 minutes ago

Covivio - Information on total number of voting rights and share capital
Published on 08/03/2026 at 18:00, 9 hours 17 minutes ago

H1 2026 revenue
Published on 08/03/2026 at 17:45, 9 hours 32 minutes ago

Monthly disclosure of the total number of shares and voting rights - July 2026
Published on 08/03/2026 at 17:45, 9 hours 32 minutes ago

Weekly share buyback
Published on 08/03/2026 at 17:40, 9 hours 37 minutes ago

Eiffage announces the end of exclusive negotiations with Atlas Arteria for the possible acquisition of the Warnow Tunnel concession in Rostock, Germany

View all LES ECHOS COMFI WIRE